SavedAdd your journal

Journals / Balkan Medical Journal / 2013 / Cilt: 2013 Sayı: 3

Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province

Neşe Kaklıkkaya
Altan Akıneden
Murat Topbaş
Faruk Aydın
Pages
—
Publication Date
2013-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mod Rheumatol 2008;18:153-60. [CrossRef]

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.
📊
Key Findings & Data:Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.
💡
Conclusion & Impact:Mod Rheumatol 2008;18:153-60. [CrossRef]
🔬Design:Makale
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Morinobu S, et al. Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]

Özet

-

🔖

Cite This Article

Kaklıkkaya, N., Akıneden, A., Topbaş, M., Aydın, F. (2013). Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal, Cilt: 2013 Sayı: 3. https://ajindex.com/articles/1373996

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009;4:1. [CrossRef]
  2. Pisetsky DS. Antinuclear antibodies in healthy people: the tip of autoimmunity’s iceberg? Arthritis Res Ther 2011;13:109-10. [CrossRef]
  3. Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoim- mune diseases. J Clin Rheumatol 2009;15:325-9. [CrossRef]
  4. de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Van- neuville B, D’Haese D, et al. Detection and identification of anti- nuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993;11:393-7.
  5. Vazquez-Del Mercado M, Gonzalez-Bernaldez M, Garcia-De La Torre I. Prevalence of antinuclear antibodies in a Huichol popula- tion of Mexico. Lupus 1995;4:164-5. [CrossRef]
  6. Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, P rigo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the se- rum of normal blood donors. Rev Hosp Clín Fac Med S Paulo 2003;58:315-9. [CrossRef]
  7. Al Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of otoantibodies in healthy adult Omanis. Ann Saudi Med 2003;23:372-5.
  8. Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear an- tibodies in the United States. Arthritis Rheum 2012;64:2319-27. [CrossRef]
  9. Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]
  10. Topbas M, Can E, Kaklikkaya N, et al. Herpes Simplex-2 serop- revalence among adults aged 20-49 in Trabzon. Nobel Med 2012;8:85-90.